ABSOLUTE BIOAVAILABILITY OF CHLORPROMAZINE, PROMAZINE AND PROMETHAZINE

被引:0
|
作者
KOYTCHEV, R
ALKEN, RG
KIRKOV, V
NESHEV, G
VAGADAY, M
KUNTER, U
机构
[1] ACAD MED SOFIA,LEHRSTUHL KLIN PHARMAKOL,SOFIA,BULGARIA
[2] BIOPHARM GMBH,BERLIN,GERMANY
来源
ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH | 1994年 / 44-1卷 / 02期
关键词
CAS; 50-53-3; 58-40-2; 60-87-7; CHLORPROMAZINE; PHARMACOKINETICS; PHENOTHIAZINE; NEUROLEPTICS; PROMAZINE; PROMETHAZINE; PROPAPHENIN(R); PROTHAZIN(R); SINOPHENIN(R);
D O I
暂无
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The absolute bioavailability of the three phenothiazine neuroleptics, promazine (Sinophenin(R), CAS 58-40-2), chlorpromazine (Propaphenin(R), CAS 50-53-3) and promethazine (Prothazin(R), CAS 60-87-7) was tested in three single-dose cross-over studies. In each trial 12 to 14 healthy volunteers were enrolled. The single doses for promazine, promethazine and chlorpromazine were 100, 75 and 150 mg (orally) and 20, 50 and 50 mg (intravenously), resp. The serum concentrations of the three neuroleptics were measured by means of a selective HPLC-method. the distribution-free confidence intervals for the absolute bioavailability of the three phenothiazines were within 10.5 to 24.7% for chlorpromazine, 7.8 to 24.9% for promazine and 12.3 to 40% for promethazine. Promazine and chlorpromazine are pharmacokinetically very similar and differ substantially from promethazine.
引用
收藏
页码:121 / 125
页数:5
相关论文
共 50 条